Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain
Cannabinoids (CBs) and particularly CB2 agonists have been shown to reduce pain andinflammation without eliciting any apparent psychotropic effect conversely to CB1agonist compounds. CBs candidates are usually lipophilic non drug-like compoundswith poor bioavailability. To serve the purpose of evalu...
Main Author: | |
---|---|
Language: | ENG |
Published: |
Université Claude Bernard - Lyon I
2012
|
Subjects: | |
Online Access: | http://tel.archives-ouvertes.fr/tel-00935588 http://tel.archives-ouvertes.fr/docs/00/93/55/88/PDF/TH2012DiazFanny.pdf |